Outcomes that
matter start here

Individualized experiences — all on one platform

Our full-spectrum weight management platform flexes to meet individual needs — whether GLP-1s are part of the plan or not — boosting engagement, controlling costs, and improving health outcomes.

WeightWatchers for Business

Real challenges, real-life results

Delivering a weight management platform that meets your organization’s objectives and employee expectations can be a challenging balancing act. We partner with you to achieve measurable, meaningful results.

balancing graphic
Stat-54.7
Stat-5.4
Stat-21
Stat-4x
Stat-1.8

Individualized experiences for everyone

Today’s WeightWatchers delivers science-backed, tech-forward weight management pathways that flex — and scale — to fit your needs.

WeightWatchers Behavioral ProgramBehavioral

Tailored nutrition and lifestyle guidance to support weight loss and beyond-the-scale outcomes.

  • Digital and IRL member engagement
  • Tracking and integrated insights
  • Individual support from registered dietitians

+ Specialized experiences that meet individualized needs, including:

Plate of healthy food

 

Diabetes

Tailored nutrition specifically designed for people living with diabetes to help them lose weight and lower blood glucose levels
ww-hiw-behavioral-glp-1-companiion-2x

 

GLP-1 Companion

Support for members taking GLP-1 medications for weight loss, focusing on nutrient-dense food and activity targets
phone screen featuring recipes. women doing yoga

43%

increase in healthy 
habits with our 
Behavioral Program6

54%

more weight loss for members taking an anti-obesity medication when combined with our Behavioral Program7
Man talking to dr virtually on ipad. Phone screen featuring WeightWatchers clinic screen

85%

maintained weight loss when switching from GLP-1 to lower-cost medication8

77%

program retention rate 
at 12 months9

RX-iconBehavioral + Clinic

Concierge clinical weight care that integrates a wide formulary of medications, including GLP-1s, with behavioral weight management for personalized support.

Full Behavioral Program, plus:

  • Virtual clinic with 24/7 access to obesity-trained specialists
  • Evidence-based prescribing protocols and medication management for a wide formulary, including GLP-1s and other anti-obesity medications
  • Individual support from registered dietitians and specialists for medication adherence
  • Real-time data trends for members and population reporting for employers

What sets us apart

Over 60+ years as a pioneer in weight management? Absolutely. 

A science-led approach that makes us the #1 doctor-recommended weight-loss program?10 Of course. 

Successful partnerships with 300+ employers and health plans based on collaboration and trust? Definitely.
But that's not all arrow

 

Male dr in white medical coat

Outcome-driven programs aligned with the latest research and backed by 180+ published studies, including  40+ randomized controlled trials. 

Group of women talking in a professional setting

Personalized coaching and 200+ community groups offering guidance, support, and accountability – available 24/7. 

Two smart phones with WeightWatcher app screens open

Tech-forward innovation powering digital tools and resources accessed through our award-winning app, including easy-to-use tracking tools, an AI-powered food scanner, and more.

Partnership that moves the needle

We have the experience to tackle your challenges — and we show up with proven solutions.

Women sitting at computer

Control costs

How to navigate the costs of weight management — whether you cover GLP-1s or not

Man using auto injector in arm

Improve outcomes

Why wraparound programs multiply the power of GLP-1 medications

Young women smiling at camera

Boost engagement

Get ready to rethink what you know about WeightWatchers

WeightWatchers app screen

Drive innovation

The latest innovations fueled by technology and science

Cover of the case study "Turning Engagement into Weight Management Success"

Real-life success: 
69% member engagement


Grab our latest case study to see our long-standing partnership with Indiana University Health in action. 

Ready to see how it all comes together?

Our full-spectrum platform flexes to align with your strategy — supporting your population, your benefits objectives, and what comes next.

Let's talk strategy.

Two men smiling, looking forwards each other with a drink. Women with closed mouth smile looking at cameraWeightWatchers what to eat app screen

1 Based on a 2024 internal analysis of WeightWatchers for Business average monthly engagement among enrolled members.
2 Based on a 12-week randomized controlled trial (n=101) that compared taking bupropion & naltrexone medications on their own to taking bupropion & naltrexone with the WeightWatchers behavioral program, including the PointsⓇ Program. Jones et al. Manuscript in draft. Funded by WW International, Inc.
3 In a study of 3,260 WW Clinic patients, patients that were prescribed a GLP-1 lost on average 21% of their body weight at 12 months. See important GLP-1 safety information.
4 Validated by Arbital Health Actuaries, a third-party actuarial firm. Does not include the cost of medication. 
5 On average, after 13 weeks.  Based on observational data from 200 individuals.
6 Based on a 6-month randomized controlled trial (n=376) that compared participants following WW to those given standard nutritional guidelines alone. Palacios et al. 2024. Manuscript in draft. Funded by WW International, Inc.
7 Based on an ongoing 12-week WW randomized controlled trial among 101 members. This analysis included 46 members at 8 weeks who were prescribed naltrexone and bupropion. Study to be completed in 2025. Apolzan JW, LaRose JG, Anton SD, Beyl RA, Greenway FL, Wickham III EP, Lanoye A, Harris MN, Martin CK, Bullard T, Foster GD. A scalable, virtual weight management program tailored for adults with type 2 diabetes: effects on glycemic control. Nutrition & Diabetes. 2023 Apr 6;13(1):3.
8 An observational study among 157 WW Clinic members who switched from a second generation GLP-1 medication to bupropion, naltrexone, or metformin and we assessed their weight loss at 13 weeks
9 Ard JD, Hong YR, Foster GF, Medcalf A, Nadolsky S, Cardel MI. Twelve-month analysis of real-world evidence from a telehealth obesity treatment provider using anti-obesity medications. Obesity 2024. 
10 Based on a 2023 survey by Cerner Enviza of 500 doctors who recommend weight loss programs to patients.
11 Based on WeightWatchers for Business internal client satisfaction survey results; Large and Jumbo Clients; Sept. 2022.
12 Mike Disclosure: For WW Points program, clinical trial participants at 6 mos. lost an avg. of 12 lbs (5.4% body weight). For WW Clinic, members lost an avg. of 0.85 lbs per week over a 12-mo. period. Based on 2022-23 study by WeightWatchers. Manuscript still under review.
13 Nancy Disclosure: *Eligible patients lost an average of 21% of their body weight (-48 lbs) in a 72-week clinical trial evaluating 15 mg tirzepatide, when paired with diet and exercise.